“Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial”, J Infect Dis, vol. 207, pp. 1888-1897, 2013.
, “Economic Evaluation of Treatment of Macular Edema Due to Central or Hemiretinal Vein Occlusion in the SCORE 2 Trial”, in Association for Research in Vision and Ophthalmology Annual Meeting, Virtual, 2021.
, “Outcomes in Children Who Underwent Transplantation for Autoimmune Hepatitis”, Liver Transpl, vol. 17, pp. 393-401, 2011.
, , “A Novel Scoring System, The Cord Blood APGAR, Predicts Engraftment after Cord Blood Transplantation: Optimization of Selection of CBUs for Transplantation.”, in ISCT 2010, Philadelphia, PA, 2010.
, “Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (HSCT).”, in American Society of Hematology 52nd Annual Meeting and Exposition, Orlando, Fl, 2010.
, “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults”, presented at the 2011, Honolulu, HI, 2011, vol. 17 No 2 Su, pp. S 185 - 186.
, “Differential Effects of Antiepileptic Drugs on Neonatal Outcomes”, Epilepsy Behav, vol. 24, pp. 449-456, 2012.
, “One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers”, N Engl J Med, vol. 371, pp. 1685-1694, 2014.
, “Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO)”, presented at the 2008, Fort Lauderdale, FL, 2008.
, “Risk Factors Associated With Incident Cataracts and Cataract Surgery in the Age-Related Eye Disease Study (AREDS): AREDS Report Number 32”, Opthalmology, vol. 118, pp. 2113-2119, 2011.
, “Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,”, Ann Intern Med, vol. 125, p. 270, 1996.
, “Time Sensitive Parameters of Immune Reconstitution Measured Between Day 100 and 1 Year Predict Survival After Unrelated Cord Blood Transplant (UCBT): The Dynamic Impact of Dendritic Cells, Tregs, and Thymic Recovery.”, in European Society of Hematology World Cord Blood Congress, Marseille, 2010.
, “Reticular Drusen as a Baseline Risk Factor for Progression to Advanced AMD in AREDS”, presented at the 01/05/2005, Fort Lauderdale, FL, 2005.
, , “AIDS Vaccine 2008 Conference”, presented at the 2008, Cape Town, South Africa, 2008.
, , “CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa”, PLoS ONE, vol. 4, p. e4401, 2009.
, “Acute Graft-Versus-Host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: A Blood and Marrow Transplant Clinical Trials Network Study”, Blood, vol. 119, pp. 3854-3860, 2012.
, , “Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2”, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2008.
“Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms”, presented at the 2008, Bangkok, Thailand, 2008.
, , , “Prevalence of Persistent Pain 3 to 5 Years Post Primary Root Canal Therapy and its Impact on Oral Health-Related Quality of Life: PEARL Network Findings”, J Endod, vol. 40, pp. 1917-1921, 2014.
, Modify or remove your filters and try again.